The price reductions could also be a boon for Medicaidd, which spent nearly $160 million on Suboxone Film in 2018. (Photo: Shutterstock)

One of the most popular and effective treatments used to fight the U.S. opioid epidemic is about to get much cheaper.

Based in Hyderabad, a rambling boomtown in south India, Dr. Reddy's Laboratories Ltd. is a major supplier of generic drugs used by Americans for everything from infections to cardiovascular ailments. After a two-year legal battle, the company has won the right to sell a cheaper version of Suboxone Film, the best-selling opioid addiction drug in the U.S. too.

Recommended For You

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.